Sophia Genetics (FRA:90B) FFO


FRA:90B Sophia Genetics SA FRA:90B
72 GF Score
Price €4.92
GF Value €4.30
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Sophia Genetics FFO?

FFO (Funds from operations) only applies to REITs.

FRA:90B
72GF Score
Sophia Genetics SA FRA:90B
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Sophia Genetics (FRA:90B) Overvalued in 2026?

Based on GuruFocus' analysis, Sophia Genetics stock appears to be overvalued. The current stock price of €4.92 is trading 14.4% above its estimated GF Value™ of €4.30. GuruFocus considers Sophia Genetics to be Modestly Overvalued.

Key valuation signals for FRA:90B:

  • FFO:
  • GF Value™: €4.30 vs. price of €4.92 (14.4% above fair value)
  • GF Score™: 72/100 with 6 warning signs

No single metric tells the full story. See the FRA:90B stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sophia Genetics Business Description

Other Exchanges SOPH:USA90B:Germany
Address La Piece 12, Rolle, CHE, CH-1180
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
72GF Score

Get the complete analysis for FRA:90B

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.92
Price
€4.30
GF Value